Scinai Immunotherapeutics's total assets for Q2 2025 were $11.84M, a decrease of 0.00% from the previous quarter. SCNI total liabilities were $3.98M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.